Загрузка...
The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia
BACKGROUND: A previous study reported that the myosin regulatory light chain interacting protein (MYLIP) might serve as a novel therapeutic class for treating dyslipidemia. It contributes to variations in the levels of circulating low-density lipoprotein cholesterol (LDL-C), promoting the degradatio...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4206345/ https://ncbi.nlm.nih.gov/pubmed/25171759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000089 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|